Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Non-Hodgkin Lymphoma (All Stages^), 2016-2020

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Recentaapc

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Recent Trends - This is an interpretation of the AAPC/APC:

AAPC/APC (95% Confidence Interval) - the change in rate over time


Other Notes


Line by Line Interpretation of the Report


US (SEER+NPCR)1


Vermont6


Minnesota6


North Carolina6


Arkansas6


Maryland6


New Jersey7


Wisconsin6


Idaho7


Mississippi6


New Hampshire6


Texas7


West Virginia6


Missouri6


Ohio6


Tennessee6


Illinois7


New York7


Rhode Island6


South Dakota6


Massachusetts7


Nebraska6


North Dakota6


Connecticut7


Kansas6


Maine6


Alabama6


Montana6


Wyoming6


Iowa7


Oregon6


Virginia6


Arizona6


California7


Kentucky7


Louisiana7


Michigan6


New Mexico7


Puerto Rico6


Colorado6


Oklahoma6


Alaska6


Utah7


Washington5


District of Columbia6


Pennsylvania6


Georgia7


Hawaii7


South Carolina6


Florida6


Delaware6


Indiana6 Nevada6

Notes:
Created by statecancerprofiles.cancer.gov on 02/26/2024 10:18 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana, Nevada

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.